Skip to main content

Peer Review reports

From: EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer

Original Submission
27 Mar 2017 Submitted Original manuscript
10 Jul 2017 Reviewed Reviewer Report - Kiyoshi Takagi
14 Jul 2017 Reviewed Reviewer Report - Olga G. Goloubeva
5 Sep 2017 Author responded Author comments - Anna Semmlinger
Resubmission - Version 2
5 Sep 2017 Submitted Manuscript version 2
24 Sep 2017 Reviewed Reviewer Report - Kiyoshi Takagi
20 Mar 2018 Author responded Author comments - Anna Semmlinger
Resubmission - Version 3
20 Mar 2018 Submitted Manuscript version 3
Publishing
21 Mar 2018 Editorially accepted
16 Apr 2018 Article published 10.1186/s12885-018-4286-9

You can find further information about peer review here.

Back to article page